Geftibenz 250 Tablets

Generic Name- Gefitinib

Drug Class- Antineoplastic agent

Gefitinib is a selective small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (EGFR TKI) used for the treatment of adults with non small cell lung cancer with activating mutations of EGFR tyrosine kinase. It acts by inhibiting EGFR, an enzyme that regulates intracellular signaling pathways essential for the proliferation and survival of cancer cells.



Geftibenz 250 (Gefitinib) tablets is an orally available anticancer drug.